News

Cell TherapiesR&D project spotlight: A collaborative approach to developing a universal ddPCR™ assay to detect residual pluripotent stem cells in cell therapy products
Filter:AllPress ReleaseCell TherapiesGene TherapiesDigital and AutomationSpin-outs, Start-ups, Sector investmentManufacturingRegulatory affairsSkills and Training
Year:All2026202520242023 →
ATTC release 2022 ATMP Clinical Adoption Forum ReportATTC release 2022 ATMP Clinical Adoption Forum ReportLearning the lessons of today to deliver the treatments of tomorrowLearning the lessons of today to deliver the treatments of tomorrowRegulatory Round-up - July 2022Regulatory Round-up - July 2022High Commission of Canada and ISED visit CGT Catapult Manufacturing Innovation CentreHigh Commission of Canada and ISED visit CGT Catapult Manufacturing Innovation CentreCGT Catapult Joins New Consortium to Advance Personalised Cell Therapy ManufacturingCGT Catapult Joins New Consortium to Advance Personalised Cell Therapy ManufacturingRegulatory Round-up - June 2022Regulatory Round-up - June 2022Representatives of Scotland’s ATMP industry get input into new CGT Catapult Edinburgh facilityRepresentatives of Scotland’s ATMP industry get input into new CGT Catapult Edinburgh facilityCell and Gene Therapy Catapult and the UK Dementia Research Institute announce collaboration to accelerate advancements in gene therapyCell and Gene Therapy Catapult and the UK Dementia Research Institute announce collaboration to accelerate advancements in gene therapyBraintree MP visits Cell and Gene Therapy Catapult facilityBraintree MP visits Cell and Gene Therapy Catapult facilityRegulatory Round-up - May 2022Regulatory Round-up - May 2022CGT Catapult works closely with NHS through Accelerated Access Collaborative to offer pioneering cell and gene treatmentsCGT Catapult works closely with NHS through Accelerated Access Collaborative to offer pioneering cell and gene treatmentsRegulatory Round-up - April 2022Regulatory Round-up - April 2022